Phase 4 Sleep Disorders Trial, Recruiting NCT04303325 Sponsor: China Medical University, China Condition: Sleep Disorders
Back to Sleep Disorders

Phase 4 Sleep Disorders Trial, Recruiting

NCT04303325
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old and have not yet reached menopause
  • People who are scheduled to have a planned (non-emergency) breast cancer operation
  • People who have been assessed by a doctor as being in generally good to mild-risk health for anaesthesia (ASA classification I or II — confirm with trial site if unsure what this means)
  • People who have scored 22 or higher on a standard depression symptom rating scale called the MADRS, indicating a significant level of depressive symptoms

Who may not be able to join:

  • People who have cognitive difficulties (such as problems with memory or thinking)
  • People who have had part or all of their stomach surgically removed at any point
  • People who have had previous surgery on their oesophagus (the tube connecting the throat to the stomach)
  • People who are unable to follow the requirements of the study for any reason
  • People who are currently taking part in another clinical trial, or who have participated in one within the last month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
China Medical University, China
Registry
ClinicalTrials.gov
Start date
8 October 2021
Est. completion
30 October 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Montgomery-asberg Depression Rating Scale score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov